Shuttle Pharmaceuticals (NASDAQ:SHPH) fell 12.43%, or USD 0.6402, to USD 4.51 in pre-market trading on November 4, 2026, implying a Tuesday close of about USD 5.15 (calculated). No company press release or regulatory filing dated November 2 to November 4, 2026 was identified, so …
Pro Medicus (ASX:PME) reported underlying earnings before interest and tax of AUD 196.1 million for FY26, 24.4% above the previous year. The underlying EBITMarginreached 74.9%, approximately 90 basis points higher. Underlying net profit after tax increased 24.1% to AUD 144.7 million. These measures describe …
For the year ended 30 June 2026, Ramsay Health Care Limited (ASX:RHC) reported revenue of AUD 18.6 billion, up 4.2%, and underlying EBIT of AUD 1.162 billion, up 11.5% on a reported basis. The underlying EBITMarginwas 6.2%, approximately 30 basis points higher. Underlying net …
Sonic Healthcare (ASX:SHL) attributed a significant share of FY26 revenue growth to acquired laboratory businesses. Its German laboratoryAcquisitioncontributed AUD 59.1 million of profit after tax in its first full year, while Swiss laboratory operations also formed part of the expansion. Acquisition contributions and organic …
Sigma Healthcare (ASX:SIG) generated AUD 10.4 billion of Australian segment revenue, up 14.9%, and AUD 1.0342 billion of normalised segment EBIT, up 18.3%. ChemistWarehousenetwork sales rose 15.9%, including 13.4% like-for-like growth. The group added 24 branded stores in Australia, taking that network to 561. …
Nanosonics published its notice of meeting on 2 October 2026. The meeting was held in person at Level 1, Building A, 7-11 Talavera Road, Macquarie Park, and online via the Meetnow platform, with registration from 10.30am AEDT.
The general meeting will begin at 10.00am Melbourne time on Tuesday 1 December 2026 at The Events Centre, Level 5, Tower 2, 727 Collins Street, Melbourne, with online participation available.Shareholdereligibility and the proxy deadline are set at 10.00am on Sunday 29 November 2026.
CSL said the Board's decision was unanimous. Waterhouse has more than 25 years' experience leading global specialty pharmaceutical businesses in the United States, the United Kingdom, continental Europe and Australia. She is Chief Executive Officer of ViiV Healthcare and President of GSK Global Health. …
Medibank Private Limited (ASX:MPL) reported a net increase of approximately 22,100 resident policyholders in FY26, equivalent to growth of about 1.1%, according to the supplied results summary. Growth was uneven across its brands: Medibank increased 0.6% while ahm rose 2.4%. Resident policyholder growth slowed …
For the six months ended 30 June 2026, Neuren Pharmaceuticals (ASX:NEU) reported revenue of AUD 42.7 million, compared with AUD 39.7 million in the prior corresponding period, according to the supplied results account. Net profit after tax was AUD 4.9 million against AUD 15.0 …